Erica Jordan
Chief Commercial Officer, Revance Therapeutics, Inc.
Companies
- Revance Therapeutics, Inc.Chief Commercial Officer Feb 29, 2024 to Feb 6, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Revance Therapeutics, Inc.0 shares2Feb 6, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 6, 2025Returned to company 107,942 shares of Revance Therapeutics, Inc.2
- Feb 4, 2025U 6,922 shares at $3.65 of Revance Therapeutics, Inc.2
- Apr 16, 2024Sold 2,392 shares at $3.80 of Revance Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Apr 17, 2024